GSA Capital Partners’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-24,670
| Closed | -$535K | – | 2046 |
|
|
2017
Q2 | $535K | Sell |
24,670
-58,136
| -70% | -$1.26M | 0.03% | 972 |
|
|
2017
Q1 | $1.16M | Buy |
82,806
+51,300
| +163% | +$720K | 0.06% | 544 |
|
|
2016
Q4 | $591K | Buy |
31,506
+17,607
| +127% | +$330K | 0.04% | 887 |
|
|
2016
Q3 | $229K | Sell |
13,899
-56,228
| -80% | -$926K | 0.01% | 1533 |
|
|
2016
Q2 | $943K | Sell |
70,127
-120,560
| -63% | -$1.62M | 0.05% | 672 |
|
|
2016
Q1 | $2.92M | Buy |
190,687
+75,940
| +66% | +$1.16M | 0.19% | 72 |
|
|
2015
Q4 | $2.28M | Sell |
114,747
-14,508
| -11% | -$288K | 0.11% | 207 |
|
|
2015
Q3 | $2.25M | Sell |
129,255
-18,700
| -13% | -$326K | 0.11% | 215 |
|
|
2015
Q2 | $2.99M | Buy |
147,955
+34,383
| +30% | +$695K | 0.11% | 179 |
|
|
2015
Q1 | $2M | Buy |
113,572
+58,112
| +105% | +$1.02M | 0.08% | 346 |
|
|
2014
Q4 | $903K | Buy |
55,460
+7,271
| +15% | +$118K | 0.06% | 537 |
|
|
2014
Q3 | $1.06M | Buy |
+48,189
| New | +$1.06M | 0.06% | 444 |
|
|
2014
Q2 | – | Sell |
-40,903
| Closed | -$760K | – | 2059 |
|
|
2014
Q1 | $760K | Sell |
40,903
-78,111
| -66% | -$1.45M | 0.05% | 482 |
|
|
2013
Q4 | $1.2M | Buy |
119,014
+7,545
| +7% | +$76.1K | 0.09% | 265 |
|
|
2013
Q3 | $1.44M | Buy |
111,469
+35,855
| +47% | +$462K | 0.11% | 194 |
|
|
2013
Q2 | $898K | Buy |
+75,614
| New | +$898K | 0.11% | 251 |
|